Slides
Page 1
Actinium Pharmaceuticals We Nuke Cancer Investor Presentation Pioneering Differentiated Radiotherapies for Patients with Unmet Needs September 2026 ATNM : NYSE AMERICAN
Actinium Pharmaceuticals We Nuke Cancer Investor Presentation Pioneering Differentiated Radiotherapies for Patients with Unmet Needs September 2026 ATNM : NYSE AMERICAN
Your watchlist and earnings event details are available after you sign in.